Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients

NCT00957385 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Revlimid

Sponsor

University Health Network, Toronto

Collaborators

[object Object]